Cochran A J, Mackie R M, Thomas C E, Grant R M, Cameron-Mowat D E, Spilg W G
Br J Cancer Suppl. 1973 Aug;1:77-82.
We have examined the effect of extracts of benign and malignant tumours on the migration of leucocytes from the peripheral blood of 55 melanoma patients, 73 breast carcinoma patients and 162 control donors in the leucocyte migration test. The leucocytes from a majority of tumour bearing patients were inhibited on contact with extracts of histogenetically similar tumours but only occasionally by extracts of dissimilar tumours and preparations from non-neoplastic breast tissue. Control donor's leucocytes were rarely inhibited by any of the tissue extracts. In both patients with malignant melanoma and those with breast carcinoma there was a striking decline in the frequency of tumour extract mediated leucocyte migration inhibition in patients with metastases.
我们在白细胞迁移试验中,检测了良性和恶性肿瘤提取物对55例黑素瘤患者、73例乳腺癌患者以及162名对照供血者外周血白细胞迁移的影响。大多数肿瘤患者的白细胞在与组织发生学上相似的肿瘤提取物接触时受到抑制,但仅偶尔受到不同肿瘤提取物及非肿瘤性乳腺组织制剂的抑制。对照供血者的白细胞很少受到任何组织提取物的抑制。在恶性黑素瘤患者和乳腺癌患者中,发生转移的患者肿瘤提取物介导的白细胞迁移抑制频率均显著下降。